Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 15, 2015
Clovis Oncology Receives Notification of PDUFA Extension for Rociletinib Download PDF format download (opens in new window)
November 16, 2015
Clovis Oncology Announces Regulatory Update for Rociletinib NDA Filing Download PDF format download (opens in new window)
November 5, 2015
Clovis Oncology Announces Third Quarter 2015 Operating Results Download PDF format download (opens in new window)
November 3, 2015
Clovis Oncology to Present at the 2015 Credit Suisse Healthcare Conference Download PDF format download (opens in new window)
October 22, 2015
Clovis Oncology to Announce Third Quarter 2015 Financial Results and Host Webcast Conference Call on November 5 Download PDF format download (opens in new window)
September 29, 2015
Clovis Oncology Announces U.S. and E.U. Regulatory Milestones for Rociletinib in the Treatment of Advanced EGFR-Mutant T790M+ Non-Small Cell Lung Cancer Download PDF format download (opens in new window)
September 23, 2015
Clovis Oncology Announces Data Presentations at 2015 European Cancer Congress Download PDF format download (opens in new window)
September 10, 2015
Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference 2015 Download PDF format download (opens in new window)
September 4, 2015
Clovis Oncology Announces Data Presentations at 16th World Conference on Lung Cancer Download PDF format download (opens in new window)
August 11, 2015
Clovis Oncology Enters into Clinical Trial Collaboration Download PDF format download (opens in new window)
August 6, 2015
Clovis Oncology Announces Second Quarter 2015 Operating Results Download PDF format download (opens in new window)
August 3, 2015
Clovis Oncology Completes U.S. and E.U. Regulatory Submissions for Rociletinib for the Treatment of Advanced EGFR-Mutant T790M+ Non-small Cell Lung Cancer Download PDF format download (opens in new window)
July 23, 2015
Clovis Oncology to Announce Second Quarter 2015 Financial Results and Host Webcast Conference Call on August 6 Download PDF format download (opens in new window)
July 10, 2015
Clovis Oncology Announces Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock Download PDF format download (opens in new window)
July 8, 2015
Clovis Oncology Announces Pricing of Public Offering of Common Stock Download PDF format download (opens in new window)
July 7, 2015
Clovis Oncology Announces Proposed Offering of Common Stock Download PDF format download (opens in new window)
July 1, 2015
Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Advanced EGFR-Mutant Non-small Cell Lung Cancer Download PDF format download (opens in new window)
June 22, 2015
Clovis Oncology Appoints Dr. Lindsey Rolfe as Chief Medical Officer Download PDF format download (opens in new window)
May 31, 2015
Clovis Oncology’s Rociletinib (CO-1686) Phase 2 Study Results Demonstrate Consistent and Promising Clinical Activity and Disease Control in Very Advanced Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Download PDF format download (opens in new window)
May 30, 2015
Clovis Oncology’s Phase 2 Studies of Rucaparib in Ovarian Cancer Demonstrate Highly Compelling Clinical Activity, in Both BRCA-mutant and BRCA-like Patients, Together Comprising Approximately 60 Percent of Patients Download PDF format download (opens in new window)
May 13, 2015
Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting Download PDF format download (opens in new window)
May 6, 2015
Clovis Oncology Announces First Quarter 2015 Operating Results Download PDF format download (opens in new window)
April 23, 2015
Clovis Oncology to Announce First Quarter 2015 Financial Results and Host Webcast Conference Call on May 6 Download PDF format download (opens in new window)
April 6, 2015
Clovis Oncology Receives Breakthrough Therapy Designation for Rucaparib for Monotherapy Treatment of Advanced Ovarian Cancer in Patients with BRCA-mutated Tumors (Inclusive of both Germline and Somatic BRCA Mutations) Download PDF format download (opens in new window)
February 25, 2015
Clovis Oncology Announces 2014 Operating Results Download PDF format download (opens in new window)
February 17, 2015
Clovis Oncology to Announce Fourth Quarter/Year-End 2014 Financial Results and Host Webcast Conference Call on February 25 Download PDF format download (opens in new window)
February 4, 2015
Clovis Oncology to Present at the 2015 Leerink Global Healthcare Conference Download PDF format download (opens in new window)
January 5, 2015
Clovis Oncology to Present at the 33rd Annual J.P. Morgan Healthcare Conference Download PDF format download (opens in new window)